Cargando…
NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells
NFE2L2 and STAT3 are key pro-survival molecules, and thus, their targeting may represent a promising anti-cancer strategy. In this study, we found that a positive feedback loop occurred between them and provided evidence that their concomitant inhibition efficiently impaired the survival of PEL cell...
Autores principales: | Arena, Andrea, Di Crosta, Michele, Gonnella, Roberta, Zarrella, Roberta, Romeo, Maria Anele, Benedetti, Rossella, Gilardini Montani, Maria Saveria, Santarelli, Roberta, D’Orazi, Gabriella, Cirone, Mara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380615/ https://www.ncbi.nlm.nih.gov/pubmed/37511362 http://dx.doi.org/10.3390/ijms241411598 |
Ejemplares similares
-
NRF2 and STAT3: friends or foes in carcinogenesis?
por: Arena, Andrea, et al.
Publicado: (2023) -
STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2020) -
Role of UPR Sensor Activation in Cell Death–Survival Decision of Colon Cancer Cells Stressed by DPE Treatment
por: Benedetti, Rossella, et al.
Publicado: (2021) -
Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross‐talk with p53 to activate p21
por: Santarelli, Roberta, et al.
Publicado: (2021) -
HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells
por: Gonnella, Roberta, et al.
Publicado: (2023)